Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid

Wagner, D; Marsoner, K; Tomberger, A; Haybaeck, J; Haas, J; Werkgartner, G; Cerwenka, H; Bacher, H; Mischinger, HJ; Kornprat, P.
Low skeletal muscle mass outperforms the Charlson Comorbidity Index in risk prediction in patients undergoing pancreatic resections.
Eur J Surg Oncol. 2018; 44(5):658-663
Web of Science PubMed FullText FullText_MUG


Autor/innen der Med Uni Graz:
Bacher Heinz
Cerwenka Herwig
Haas Josef
Haybäck Johannes
Kornprat Peter
Marsoner Katharina
Mischinger Hans-Joerg
Wagner Doris
Werkgartner Georg

Dimensions Citations:

Plum Analytics:
Low skeletal muscle mass is a known predictor of morbidity and mortality in patients undergoing major pancreatic surgeries. We sought to combine low skeletal muscle mass with established risk predictors to improve their prognostic capacity for postoperative outcome and morbidity. As established parameters to predict preoperative mortality risk for patients, the ASA classification and the Charlson Comorbidity Index (CCI) were used. The Hounsfield Units Average Calculation (HUAC) was measured to define low skeletal muscle mass in 424 patients undergoing pancreatic resections for malignancies. Patients in the lowest sex-adjusted quartile for HUAC were defined as having low skeletal muscle mass (muscle wasting). Multivariable Cox regression analysis was utilized to identify preoperative risk factors associated with postoperative morbidity. Median patient age was 63 years (19-87), 47.9% patients were male, and half the cohort had multiple comorbidities (Charlson Comorbidity Index [CCI]>6, 63.2%), 30-day mortality was 5.8% (n = 25). Median HUAC was 19.78 HU (IQR: 15.94-23.54) with 145 patients (34.2%) having low skeletal muscle mass. Preoperative frailty defined by low skeletal muscle mass was associated with an increased risk for postoperative complications (OR 1.55, CI 95% 0.98-2.45, p = 0.014), and a higher 30-day mortality (HR 5.17, CI 95% 1.57-16.69, p = 0.004). With an AUC of 0.85 HUAC showed the highest predictability for 30-day mortality (CI 95% 0.78-0.91, p = 0.0001). Patients with CCI ≥6 and low skeletal muscle mass defined by the HUAC had a 9.78 higher risk of dying in the immediate postoperative phase (HR 9.78, CI 95% 2.98-12.2, p = 0.0001). Low skeletal muscle mass predicts postoperative mortality and complications best and it should be incorporated to conventional risk scores to identify high risk patients. Copyright © 2018 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.
Find related publications in this database (using NLM MeSH Indexing)
Adult -
Aged -
Aged, 80 and over -
Carcinoma - epidemiology
Carcinoma - surgery
Comorbidity -
Female -
Frailty - diagnostic imaging
Frailty - epidemiology
Humans -
Male -
Middle Aged -
Mortality -
Multivariate Analysis -
Muscle, Skeletal - diagnostic imaging
Muscle, Skeletal - pathology
Organ Size -
Pancreatic Neoplasms - epidemiology
Pancreatic Neoplasms - surgery
Pancreaticoduodenectomy -
Postoperative Complications - epidemiology
Prognosis -
Proportional Hazards Models -
Psoas Muscles - diagnostic imaging
Psoas Muscles - pathology
Risk Assessment -
Tomography, X-Ray Computed -
Young Adult -

Find related publications in this database (Keywords)
Low skeletal muscle mass
Outcome prediction
Hepatobiliary surgery
Charlson Comorbidity Index
© Med Uni Graz Impressum